These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38075128)

  • 21. Retracted: Identification of Prognostic Fatty Acid Metabolism lncRNAs and Potential Molecular Targeting Drugs in Uveal Melanoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9813652. PubMed ID: 38077905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retracted: Effectiveness and Prognosis: Drainage Skin-Bridge Sparing Surgery Combined with Fistulotomy versus Fistulotomy Only in the Treatment of Anal Fistula.
    Engineering JOH
    J Healthc Eng; 2023; 2023():9843708. PubMed ID: 36741867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction.
    Li H; Sun X; Zhao Y; Zhang C; Jiang K; Ren J; Xing L; He M
    BMC Cancer; 2023 Jun; 23(1):528. PubMed ID: 37296415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retracted: KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma.
    International BR
    Biomed Res Int; 2023; 2023():9857986. PubMed ID: 37564142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retracted: Red Blood Cell Membrane-Camouflaged Gold Nanoparticles for Treatment of Melanoma.
    Oncology JO
    J Oncol; 2023; 2023():9835164. PubMed ID: 37476551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Retracted] MicroRNA‑203 inhibits malignant melanoma cell migration by targeting versican.
    Bu P; Yang P
    Exp Ther Med; 2024 Jan; 27(1):21. PubMed ID: 38125350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression pattern of immune-related genes and characterization of tumor immune microenvironment: predicting prognosis and immunotherapeutic effects in cutaneous melanoma.
    Dong D; Wang W; Wang H; Chen L; Liu T
    World J Surg Oncol; 2022 Sep; 20(1):303. PubMed ID: 36138406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9870383. PubMed ID: 37621621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retracted: A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9829630. PubMed ID: 37946834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retracted: The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    International BR
    Biomed Res Int; 2023; 2023():9809182. PubMed ID: 37539017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retracted: Cluster-Based Immunotherapy for Patients with Recurrent Abortion Caused by Antiphospholipid Syndrome.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9823463. PubMed ID: 37476769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retracted: Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9813418. PubMed ID: 37387737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retracted: A Potential Prognostic Biomarker for Glioma: Aldo-Keto Reductase Family 1 Member B1.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9798269. PubMed ID: 37829854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9859381. PubMed ID: 37811306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retracted: A Ferroptosis-Related Gene Signature for Predicting Survival and Immunotherapy Effect in Renal Cancer.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9835478. PubMed ID: 37503419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.
    Huang FX; Wu JW; Cheng XQ; Wang JH; Wen XZ; Li JJ; Zhang Q; Jiang H; Ding QY; Zhu XF; Zhang XS; Ding Y; Li DD
    Front Immunol; 2022; 13():902167. PubMed ID: 36003385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retracted: Bioinformatics Analysis Reveals the Biomarker Value and Potential Mechanism of miR-675-3p in Gastric Cancer.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9804746. PubMed ID: 38074368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retracted: PD-1 Is an Immune-Inflammatory Potential Biomarker in Cerebrospinal Fluid and Serum of Intractable Epilepsy.
    International BR
    Biomed Res Int; 2024; 2024():9753606. PubMed ID: 38230152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retracted: Changes of Tumor Markers in Patients with Lung Cancer after Immunotherapy and Their Link with Inflammation in the Body.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9780189. PubMed ID: 37475926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9814782. PubMed ID: 37416228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.